LYRA THERAPEUTICS INC (LYRA)
US55234L1052 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.80M | 22.35M | 32.60M | 45.70M | 74.60M | |||
| Marketable Securities | 71.32M | 80.40M | 65.30M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.33M | 2.07M | 2.90M | 2.20M | 1.30M | |||
| Total Current Assets | 89.44M | 104.82M | 100.80M | 47.90M | 75.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 49.41M | 35.28M | 4.50M | 5.90M | 4.50M | |||
| Other Non-Current Assets | 2.67M | 2.50M | 4.70M | 1.10M | 400.00K | |||
| Total Non-Current Assets | 52.08M | 37.78M | 9.20M | 7.00M | 4.90M | |||
| TOTAL ASSETS | 141.53M | 142.60M | 110.00M | 54.90M | 80.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.56M | 14.81M | 10.60M | 5.30M | 4.00M | |||
| Accounts Payable | 2.84M | 3.13M | 2.60M | 3.10M | 900.00K | |||
| Other Current Liabilities | 1.32M | 1.66M | 1.30M | 9.80M | N/A | |||
| Total Current Liabilities | 18.72M | 19.60M | 14.50M | 18.20M | 4.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 45.30M | 33.58M | 14.70M | 2.30M | 1.50M | |||
| Total Non-Current Liabilities | 45.30M | 33.58M | 14.70M | 2.40M | 1.40M | |||
| TOTAL LIABILITIES | 64.02M | 53.18M | 29.20M | 20.60M | 6.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -333.81M | -311.36M | -248.70M | -193.40M | -149.90M | |||
| Additional Paid In Capital | 411.23M | 400.69M | 329.40M | 227.70M | 224.40M | |||
| Common Shares | 61.00K | 57.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 25.00K | 33.00K | 0.00 | N/A | N/A | |||
| Shares Outstanding | 60.96M | 57.21M | 31.80M | 13.00M | 12.90M | |||
| Tangible Book Value per Share | 1.27 | 1.56 | 2.54 | 2.64 | 5.78 | |||
| Total Shareholders' Equity | 77.50M | 89.42M | 80.80M | 34.30M | 74.50M | |||
| TOTAL LIABILITIES AND EQUITY | 141.53M | 142.60M | 110.00M | 54.90M | 80.80M | |||
| Statistics | ||||||||
| Current Ratio | 4.78 | 5.35 | 6.95 | 2.63 | 15.49 | |||
| Return On Assets (ROA) | -48.67% | -43.96% | -50.25% | -79.25% | -27.52% | |||
| Return On Equity (ROE) | -88.87% | -70.10% | -68.42% | -126.85% | -29.85% | |||
All data in USD